fluorouracil and gw9662
fluorouracil has been researched along with gw9662 in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Benko, I; Djazayeri, K; Kiss, A; Nagy, L; Németh, J; Peitl, B; Szabó, B; Szilvássy, Z | 1 |
| Cao, JG; Dong, L; Liu, HQ; Qin, Y; Sun, L; Tang, XQ; Xia, H; Zhang, YQ | 1 |
| Hu, J; Jing, X; Li, W; Su, P; Wang, X; Wu, X; Zhang, H; Zhang, X; Zhou, G | 1 |
Other Studies
5 other study(ies) available for fluorouracil and gw9662
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Accelerated recovery of 5-fluorouracil-damaged bone marrow after rosiglitazone treatment.
Topics: Administration, Oral; Anilides; Animals; Antimetabolites, Antineoplastic; Blood Glucose; Bone Marrow; Bone Marrow Cells; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Female; Fluorouracil; Granulocyte Precursor Cells; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Hypoglycemic Agents; Injections, Intraperitoneal; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Rosiglitazone; Thiazolidinediones; Time Factors | 2005 |
Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor gamma.
Topics: Anilides; Antimetabolites, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Fluorouracil; Gene Expression Regulation; Humans; Hypoglycemic Agents; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rosiglitazone; Thiazolidinediones | 2007 |
Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes.
Topics: Active Transport, Cell Nucleus; Anilides; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta Catenin; Cell Line, Tumor; Cell Nucleus; Cisplatin; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorouracil; Frizzled Receptors; Humans; Ovarian Neoplasms; Paclitaxel; PPAR gamma; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription, Genetic; Wnt Proteins | 2015 |